. . . . . . . . . . . . . "p(HGNC:IFNB1) -| p(HGNC:TNF)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "IFNB1 decreased mRNA expression of TNF-alpha and IFN-gamma. Protein levels of these two pro-inflammatory cytokines also were reduced in MS patients on treatment with IFNB1 when compared with normal subjects. TNF-alpha production increased after one year of therapy, reaching values similar to that of healthy controls but the IFN-gamma secretion continued to remain low." . . "Selventa" . . . . "2014-07-03T14:29:47.390+02:00"^^ . . .